The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis

Brianne E. Barker, Megan M. Hanlon, Viviana Marzaioli, Conor M. Smith, Clare C. Cunningham, Jean M. Fletcher, Douglas J. Veale, Ursula Fearon, Mary Canavan

Open source

DOI: 10.3389/fmed.2023.1029021
Published: 2023-02-03
Container: Frontiers in Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2023.1029021,
  title = {The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis},
  author = {Brianne E. Barker and Megan M. Hanlon and Viviana Marzaioli and Conor M. Smith and Clare C. Cunningham and Jean M. Fletcher and Douglas J. Veale and Ursula Fearon and Mary Canavan},
  year = {2023},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2023.1029021},
  url = {https://doi.org/10.3389/fmed.2023.1029021}
}

RIS

TY  - JOUR
TI  - The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis
AU  - Brianne E. Barker
AU  - Megan M. Hanlon
AU  - Viviana Marzaioli
AU  - Conor M. Smith
AU  - Clare C. Cunningham
AU  - Jean M. Fletcher
AU  - Douglas J. Veale
AU  - Ursula Fearon
AU  - Mary Canavan
PY  - 2023
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2023.1029021
UR  - https://doi.org/10.3389/fmed.2023.1029021
ER  -

APA

Barker, B. E., Hanlon, M. M., Marzaioli, V., Smith, C. M., Cunningham, C. C., Fletcher, J. M., Veale, D. J., Fearon, U., & Canavan, M. (2023). The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis. Frontiers in Medicine. https://doi.org/10.3389/fmed.2023.1029021

Source records

crossref · retrieved 2026-09-25T21:20:10.472Z